Concepedia

Wesley Jakubiec

WJ

Statistics

Publications

6

Citations

377

H-Index

6

Active since

2010

Affiliations

VA Connecticut Healthcare System(Current)

Pfizer (United States)

Yale University

The University of Texas Health Science Center at Tyler

Yale New Haven Hospital

Wesley Jakubiec is an author at VA Connecticut Healthcare System specializing in tuberculosis pharmacotherapy, pharmacology, and bactericidal agents.

ORCID

Publications per year

2010–2017

6

Publications

6

Biomarker-Assisted Dose Selection for Safety and Efficacy in Early Development of PNU-100480 for Tuberculosis

Robert S. Wallis, Wesley Jakubiec, Vikas Kumar et al. · Antimicrobial Agents and Chemotherapy · 2010 · 128 citations · Full text

, , +14

Pharmacokinetics and Whole‐Blood Bactericidal Activity against<i>Mycobacterium tuberculosis</i>of Single Doses of PNU‐100480 in Healthy Volunteers

Robert S. Wallis, Wesley Jakubiec, Vikas Kumar et al. · The Journal of Infectious Diseases · 2010 · 102 citations · Full text

, , +12

Rapid Evaluation in Whole Blood Culture of Regimens for XDR-TB Containing PNU-100480 (Sutezolid), TMC207, PA-824, SQ109, and Pyrazinamide

Robert S. Wallis, Wesley Jakubiec, Mark J. Mitton‐Fry et al. · PLoS ONE · 2012 · 74 citations · Full text

, , +15

SQ109 and PNU-100480 interact to kill Mycobacterium tuberculosis in vitro

Venkata M. Reddy, Tia Dubuisson, Leo Einck et al. · Journal of Antimicrobial Chemotherapy · 2012 · 44 citations · Full text

, , +10

First Report of Mycobacterium canariasense Catheter-Related Bacteremia in the Americas

Alberto Paniz‐Mondolfi, Lynn Ladutko, Barbara A. Brown‐Elliott et al. · Journal of Clinical Microbiology · 2014 · 17 citations · Full text

, , +16

1–5 of 6